Suchergebnisse - Llombart-Cussac, Antonio
- Treffer 1 - 20 von 37
- Zur nächsten Seite
-
1
Surrogate endpoints for early-stage breast cancer: a review of the state of the art, controversies, and future prospects von Gion, María, Pérez-García, José Manuel, Llombart-Cussac, Antonio, Sampayo-Cordero, Miguel, Cortés, Javier, Malfettone, Andrea
Veröffentlicht 2021Text -
2
Immune checkpoint inhibitors: a physiology-driven approach to the treatment of coronavirus disease 2019 von Di Cosimo, Serena, Malfettone, Andrea, Pérez-García, José M., Llombart-Cussac, Antonio, Miceli, Rosalba, Curigliano, Giuseppe, Cortés, Javier
Veröffentlicht 2020Text -
3
-
4
Soluble Biomarkers with Prognostic and Predictive Value in Advanced Non-Small Cell Lung Cancer Treated with Immunotherapy von Honrubia-Peris, Beatriz, Garde-Noguera, Javier, García-Sánchez, Jose, Piera-Molons, Nuria, Llombart-Cussac, Antonio, Fernández-Murga, María Leonor
Veröffentlicht 2021Text -
5
Role of RAS mutation status as a prognostic factor for patients with advanced colorectal cancer treated with first-line chemotherapy based on fluoropyrimidines and oxaliplatin, wit... von Garde Noguera, Javier, Jantus-Lewintre, Eloisa, Gil-Raga, Mireia, Evgenyeva, Elena, Maciá Escalante, Sonia, Llombart-Cussac, Antonio, Camps Herrero, Carlos
Veröffentlicht 2017Text -
6
-
7
The Value of Case Reports in Systematic Reviews from Rare Diseases. The Example of Enzyme Replacement Therapy (ERT) in Patients with Mucopolysaccharidosis Type II (MPS-II) von Sampayo-Cordero, Miguel, Miguel-Huguet, Bernat, Malfettone, Andrea, Pérez-García, José Manuel, Llombart-Cussac, Antonio, Cortés, Javier, Pardo, Almudena, Pérez-López, Jordi
Veröffentlicht 2020Text -
8
The Impact of Excluding Nonrandomized Studies From Systematic Reviews in Rare Diseases: “The Example of Meta-Analyses Evaluating the Efficacy and Safety of Enzyme Replacement Thera... von Sampayo-Cordero, Miguel, Miguel-Huguet, Bernat, Malfettone, Andrea, Pérez-García, José Manuel, Llombart-Cussac, Antonio, Cortés, Javier, Pardo, Almudena, Pérez-López, Jordi
Veröffentlicht 2021Text -
9
-
10
Prognostic characteristics in hormone receptor-positive advanced breast cancer and characterization of abemaciclib efficacy von Di Leo, Angelo, O’Shaughnessy, Joyce, Sledge, George W., Martin, Miguel, Lin, Yong, Frenzel, Martin, Hardebeck, Molly C., Smith, Ian C., Llombart-Cussac, Antonio, Goetz, Matthew P., Johnston, Stephen
Veröffentlicht 2018Text -
11
Progress Against Solid Tumors in Danger: The Metastatic Breast Cancer Example von Cortés, Javier, Calvo, Emiliano, González-Martín, Antonio, Dawood, Shaheenah, Llombart-Cussac, Antonio, De Mattos-Arruda, Leticia, Gómez, Patricia, Silva, Orlando, Perez, Edith A., Rugo, Hope S., Lluch, Ana, Hortobagyi, Gabriel N.
Veröffentlicht 2012Text -
12
Impact of SARS-CoV-2 Infection on Patients with Cancer: Retrospective and Transversal Studies in Spanish Population von Garde-Noguera, Javier, Fernández-Murga, M. Leonor, Giner-Bosch, Vicent, Dominguez-Márquez, Victoria, Sánchez, José García, Soler-Cataluña, Juan José, López Chuliá, Franscica, Honrubia, Beatriz, Piera, Nuria, Llombart-Cussac, Antonio
Veröffentlicht 2020Text -
13
Agreement between results of meta-analyses from case reports and clinical studies, regarding efficacy and safety of idursulfase therapy in patients with mucopolysaccharidosis type... von Sampayo-Cordero, Miguel, Miguel-Huguet, Bernat, Pardo-Mateos, Almudena, Malfettone, Andrea, Pérez-García, José, Llombart-Cussac, Antonio, Cortés, Javier, Moltó-Abad, Marc, Muñoz-Delgado, Cecilia, Pérez-Quintana, Marta, Pérez-López, Jordi
Veröffentlicht 2019Text -
14
Differences in circulating γδ T cells in patients with primary colon cancer and relation with prognostic factors von Andreu-Ballester, Juan Carlos, Galindo-Regal, Lorena, Hidalgo-Coloma, Julia, Cuéllar, Carmen, García-Ballesteros, Carlos, Hurtado, Carolina, Uribe, Natalia, del Carmen Martín, María, Jiménez, Ana Isabel, López-Chuliá, Francisca, Llombart-Cussac, Antonio
Veröffentlicht 2020Text -
15
Inclusion of non-inferiority analysis in superiority-based clinical trials with single-arm, two-stage Simon's design von Sampayo-Cordero, Miguel, Miguel-Huguet, Bernat, Pérez-García, José, Páez, David, Guerrero-Zotano, Ángel L., Garde-Noguera, Javier, Aguirre, Elena, Holgado, Esther, López-Miranda, Elena, Huang, Xin, Malfettone, Andrea, Llombart-Cussac, Antonio, Cortés, Javier
Veröffentlicht 2020Text -
16
Japanese subpopulation analysis of MONARCH 2: phase 3 study of abemaciclib plus fulvestrant for treatment of hormone receptor-positive, human epidermal growth factor receptor 2-neg... von Inoue, Kenichi, Masuda, Norikazu, Iwata, Hiroji, Takahashi, Masato, Ito, Yoshinori, Miyoshi, Yasuo, Nakayama, Takahiro, Mukai, Hirofumi, van der Walt, Jan-Stefan, Mori, Joji, Sakaguchi, Sachi, Kawaguchi, Tsutomu, Tanizawa, Yoshinori, Llombart-Cussac, Antonio, Sledge, George W., Toi, Masakazu
Veröffentlicht 2021Text -
17
Trastuzumab Emtansine Plus Non-Pegylated Liposomal Doxorubicin in HER2-Positive Metastatic Breast Cancer (Thelma): A Single-Arm, Multicenter, Phase Ib Trial von López-Miranda, Elena, Pérez-García, José Manuel, Di Cosimo, Serena, Brain, Etienne, Ravnik, Maja, Escrivá-de-Romaní, Santiago, Vidal, Maria, Gligorov, Joseph, Borštnar, Simona, Calabuig, Laura, Sampayo-Cordero, Miguel, Malfettone, Andrea, Llombart-Cussac, Antonio, Suter, Thomas M., Cortés, Javier
Veröffentlicht 2020Text -
18
A polymorphism at the 3'-UTR region of the aromatase gene defines a subgroup of postmenopausal breast cancer patients with poor response to neoadjuvant letrozole von Garcia-Casado, Zaida, Guerrero-Zotano, Angel, Llombart-Cussac, Antonio, Calatrava, Ana, Fernandez-Serra, Antonio, Ruiz-Simon, Amparo, Gavila, Joaquin, Climent, Miguel A, Almenar, Sergio, Cervera-Deval, Jose, Campos, Josefina, Albaladejo, Carlos Vazquez, Llombart-Bosch, Antonio, Guillem, Vicente, Lopez-Guerrero, Jose A
Veröffentlicht 2010Text -
19
The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor–Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy—MONARCH 2: A Randomiz... von Sledge, George W., Toi, Masakazu, Neven, Patrick, Sohn, Joohyuk, Inoue, Kenichi, Pivot, Xavier, Burdaeva, Olga, Okera, Meena, Masuda, Norikazu, Kaufman, Peter A., Koh, Han, Grischke, Eva-Maria, Conte, PierFranco, Lu, Yi, Barriga, Susana, Hurt, Karla, Frenzel, Martin, Johnston, Stephen, Llombart-Cussac, Antonio
Veröffentlicht 2019Text -
20
Neoadjuvant eribulin in HER2-negative early-stage breast cancer (SOLTI-1007-NeoEribulin): a multicenter, two-cohort, non-randomized phase II trial von Pascual, Tomás, Oliveira, Mafalda, Villagrasa, Patricia, Ortega, Vanesa, Paré, Laia, Bermejo, Begoña, Morales, Serafín, Amillano, Kepa, López, Rafael, Galván, Patricia, Canes, Jordi, Salvador, Fernando, Nuciforo, Paolo, Rubio, Isabel T., Llombart-Cussac, Antonio, Di Cosimo, Serena, Baselga, José, Harbeck, Nadia, Prat, Aleix, Cortés, Javier
Veröffentlicht 2021Text